A detailed history of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main holds 373,760 shares of GILD stock, worth $33.7 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
373,760
Previous 398,130 6.12%
Holding current value
$33.7 Million
Previous $27.3 Million 14.69%
% of portfolio
0.03%
Previous 0.03%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$66.59 - $83.99 $1.62 Million - $2.05 Million
-24,370 Reduced 6.12%
373,760 $31.3 Million
Q2 2024

Aug 14, 2024

BUY
$63.15 - $72.88 $6.54 Million - $7.54 Million
103,490 Added 35.12%
398,130 $27.3 Million
Q1 2024

May 15, 2024

SELL
$71.58 - $87.29 $3.16 Million - $3.85 Million
-44,096 Reduced 13.02%
294,640 $21.6 Million
Q4 2023

Feb 14, 2024

SELL
$73.27 - $83.09 $620,523 - $703,689
-8,469 Reduced 2.44%
338,736 $27.4 Million
Q3 2023

Nov 14, 2023

SELL
$73.94 - $80.67 $35.5 Million - $38.7 Million
-479,705 Reduced 58.01%
347,205 $26 Million
Q2 2023

May 17, 2024

BUY
$76.01 - $86.7 $40.5 Million - $46.1 Million
532,270 Added 180.65%
826,910 $63.7 Million
Q2 2023

Aug 14, 2023

SELL
$76.01 - $86.7 $29 Million - $33.1 Million
-381,738 Reduced 31.58%
826,910 $63.7 Million
Q1 2023

May 17, 2024

BUY
$77.31 - $88.08 $43 Million - $49 Million
556,288 Added 85.27%
1,208,648 $100 Million
Q1 2023

May 15, 2023

BUY
$77.31 - $88.08 $43 Million - $49 Million
556,288 Added 85.27%
1,208,648 $100 Million
Q4 2022

May 17, 2024

BUY
$62.32 - $89.47 $22.3 Million - $32 Million
357,720 Added 121.41%
652,360 $56 Million
Q4 2022

Feb 14, 2023

BUY
$62.32 - $89.47 $7.12 Million - $10.2 Million
114,296 Added 21.24%
652,360 $56 Million
Q3 2022

Nov 14, 2022

SELL
$59.54 - $68.01 $2.27 Million - $2.6 Million
-38,180 Reduced 6.63%
538,064 $33.2 Million
Q2 2022

Aug 15, 2022

SELL
$57.72 - $65.01 $4.6 Million - $5.18 Million
-79,649 Reduced 12.14%
576,244 $35.6 Million
Q1 2022

May 16, 2022

BUY
$57.92 - $72.58 $11 Million - $13.8 Million
190,033 Added 40.79%
655,893 $39 Million
Q4 2021

Feb 14, 2022

SELL
$64.88 - $73.64 $24.5 Million - $27.8 Million
-378,162 Reduced 44.8%
465,860 $34.2 Million
Q3 2021

Nov 15, 2021

BUY
$67.69 - $73.03 $9.85 Million - $10.6 Million
145,585 Added 20.84%
844,022 $59 Million
Q2 2021

Aug 16, 2021

BUY
$63.47 - $69.35 $28.7 Million - $31.4 Million
452,151 Added 183.59%
698,437 $48.1 Million
Q1 2021

May 17, 2021

SELL
$60.0 - $68.46 $16.7 Million - $19 Million
-277,907 Reduced 53.02%
246,286 $15.9 Million
Q4 2020

Feb 16, 2021

SELL
$56.65 - $64.55 $48 Million - $54.7 Million
-847,961 Reduced 61.8%
524,193 $29.9 Million
Q3 2020

Nov 16, 2020

SELL
$62.1 - $78.08 $1.93 Million - $2.42 Million
-31,020 Reduced 2.21%
1,372,154 $86.7 Million
Q2 2020

Aug 14, 2020

SELL
$72.34 - $84.0 $37 Million - $43 Million
-511,682 Reduced 26.72%
1,403,174 $108 Million
Q1 2020

May 15, 2020

BUY
$62.63 - $80.22 $24.1 Million - $30.9 Million
384,580 Added 25.13%
1,914,856 $143 Million
Q4 2019

Feb 14, 2020

BUY
$61.62 - $67.78 $18.3 Million - $20.2 Million
297,360 Added 24.12%
1,530,276 $99.4 Million
Q3 2019

Nov 14, 2019

BUY
$62.51 - $69.0 $1.48 Million - $1.64 Million
23,750 Added 1.96%
1,232,916 $78.1 Million
Q2 2019

Aug 14, 2019

SELL
$61.87 - $69.38 $37.4 Million - $41.9 Million
-604,232 Reduced 33.32%
1,209,166 $81.7 Million
Q1 2019

May 15, 2019

SELL
$62.53 - $70.05 $4.47 Million - $5.01 Million
-71,563 Reduced 3.8%
1,813,398 $118 Million
Q4 2018

Feb 14, 2019

SELL
$60.54 - $79.0 $61.8 Million - $80.7 Million
-1,021,453 Reduced 35.14%
1,884,961 $117 Million
Q3 2018

Nov 14, 2018

BUY
$71.28 - $78.92 $116 Million - $128 Million
1,621,623 Added 126.22%
2,906,414 $0
Q2 2018

Apr 15, 2019

BUY
$64.88 - $75.68 $397,844 - $464,069
6,132 Added 0.48%
1,284,791 $91 Million
Q2 2018

Aug 14, 2018

SELL
$64.88 - $75.68 $11.3 Million - $13.2 Million
-174,350 Reduced 12.0%
1,278,659 $90.6 Million
Q1 2018

May 15, 2018

BUY
$72.84 - $88.8 $23.5 Million - $28.7 Million
322,677 Added 28.55%
1,453,009 $107 Million
Q4 2017

Feb 14, 2018

BUY
$71.15 - $83.52 $3.84 Million - $4.51 Million
53,977 Added 5.01%
1,130,332 $81 Million
Q3 2017

Nov 14, 2017

BUY
$72.11 - $85.47 $77.6 Million - $92 Million
1,076,355
1,076,355 $87.2 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Portfolio

Follow Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.